Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Cannabidiol as potential anticancer drug.

Massi P, Solinas M, Cinquina V, Parolaro D.

Br J Clin Pharmacol. 2013 Feb;75(2):303-12. doi: 10.1111/j.1365-2125.2012.04298.x. Review.

2.

Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.

McPartland JM, Duncan M, Di Marzo V, Pertwee RG.

Br J Pharmacol. 2015 Feb;172(3):737-53. doi: 10.1111/bph.12944. Review.

3.

Therapeutic potential of cannabinoids in CNS disease.

Croxford JL.

CNS Drugs. 2003;17(3):179-202. Review.

PMID:
12617697
4.

Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.

Fraguas-Sánchez AI, Fernández-Carballido A, Torres-Suárez AI.

Expert Opin Investig Drugs. 2016 Nov;25(11):1311-1323. Epub 2016 Sep 28. Review.

PMID:
27633508
5.

Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature.

Fowler CJ.

Clin Pharmacol Ther. 2015 Jun;97(6):587-96. doi: 10.1002/cpt.84. Epub 2015 May 2. Review.

PMID:
25669486
6.

Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke.

Hayakawa K, Mishima K, Fujiwara M.

Pharmaceuticals (Basel). 2010 Jul 8;3(7):2197-2212. Review.

7.

Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.

Fasinu PS, Phillips S, ElSohly MA, Walker LA.

Pharmacotherapy. 2016 Jul;36(7):781-96. doi: 10.1002/phar.1780. Review.

PMID:
27285147
8.

A systematic review of the antipsychotic properties of cannabidiol in humans.

Iseger TA, Bossong MG.

Schizophr Res. 2015 Mar;162(1-3):153-61. doi: 10.1016/j.schres.2015.01.033. Epub 2015 Feb 7. Review.

PMID:
25667194
9.

Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective.

Karst M, Wippermann S.

Expert Opin Investig Drugs. 2009 Feb;18(2):125-33. doi: 10.1517/13543780802691951 . Review.

PMID:
19236260
10.

Cannabidiol: State of the art and new challenges for therapeutic applications.

Pisanti S, Malfitano AM, Ciaglia E, Lamberti A, Ranieri R, Cuomo G, Abate M, Faggiana G, Proto MC, Fiore D, Laezza C, Bifulco M.

Pharmacol Ther. 2017 Jul;175:133-150. doi: 10.1016/j.pharmthera.2017.02.041. Epub 2017 Feb 22. Review.

PMID:
28232276
11.

Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?

Oesch S, Gertsch J.

J Pharm Pharmacol. 2009 Jul;61(7):839-53. doi: 10.1211/jpp/61.07.0002. Review.

PMID:
19589225
12.

Phytocannabinoids as novel therapeutic agents in CNS disorders.

Hill AJ, Williams CM, Whalley BJ, Stephens GJ.

Pharmacol Ther. 2012 Jan;133(1):79-97. doi: 10.1016/j.pharmthera.2011.09.002. Epub 2011 Sep 6. Review.

PMID:
21924288
13.

Pharmacology of cannabinoids.

Grotenhermen F.

Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):14-23. Review.

PMID:
15159677
14.

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

Fernández-Ruiz J, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R, Martínez-Orgado J.

Br J Clin Pharmacol. 2013 Feb;75(2):323-33. doi: 10.1111/j.1365-2125.2012.04341.x. Review.

15.

Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.

Burns TL, Ineck JR.

Ann Pharmacother. 2006 Feb;40(2):251-60. Epub 2006 Jan 31. Review.

PMID:
16449552
16.

Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.

De Petrocellis L, Di Marzo V.

J Neuroimmune Pharmacol. 2010 Mar;5(1):103-21. doi: 10.1007/s11481-009-9177-z. Epub 2009 Oct 22. Review.

PMID:
19847654
17.

Endocannabinoid system and mood disorders: priming a target for new therapies.

Micale V, Di Marzo V, Sulcova A, Wotjak CT, Drago F.

Pharmacol Ther. 2013 Apr;138(1):18-37. doi: 10.1016/j.pharmthera.2012.12.002. Epub 2012 Dec 20. Review.

PMID:
23261685
18.

Cannabis and cannabinoids: pharmacology and rationale for clinical use.

Pertwee RG.

Forsch Komplementarmed. 1999 Oct;6 Suppl 3:12-5. Review.

PMID:
10575283
19.

Cannabidiol--recent advances.

Mechoulam R, Peters M, Murillo-Rodriguez E, Hanus LO.

Chem Biodivers. 2007 Aug;4(8):1678-92. Review.

PMID:
17712814
20.

The therapeutic potential of the endocannabinoid system for Alzheimer's disease.

Karl T, Cheng D, Garner B, Arnold JC.

Expert Opin Ther Targets. 2012 Apr;16(4):407-20. doi: 10.1517/14728222.2012.671812. Epub 2012 Mar 27. Review.

PMID:
22448595

Supplemental Content

Support Center